Our team launched a TikTok ad series targeting COVID-19 vaccine-hesitant individuals and those potentially not convinced about mRNA vaccines. With 31% of people ages 5 and up in the US not having completed their primary vaccine series and 69% needing to receive a booster dose, we knew we had to educate this audience about Novavax and its protein-based vaccine technology. Our ads were designed to engage and inform the 135 million US users on TikTok. The series was hugely successful, with click-through rates way above
benchmarks.